New daily pill for obesity shows promise in early trial
NCT ID NCT07652047
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tests a new daily pill called CX11 in 90 adults with obesity or overweight who also have weight-related health problems like high blood pressure or prediabetes. The study aims to see if the pill is safe and helps with weight loss compared to a placebo. Participants will take the pill for a set period, and researchers will track changes in body weight.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CX11 tablets
What this could lead to
If successful, this could lead to a new daily pill for weight loss in people with obesity or weight-related health issues.
What could go wrong
This is an early Phase 1b trial with only 90 participants, so safety and effectiveness are not yet proven. The drug may not work or could have side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Corxel Investigational Site
RECRUITINGAustin, Texas, 78744, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Corxel Investigational site
RECRUITINGLas Vegas, Nevada, 89113, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••